ArticlePloS one2013

Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation.

Christina Pachel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.